MLA medical australia limited

Ann: Annual Report, page-4

  1. 24 Posts.
    I think that the next quarterly report is definitely the one to look at.
    The reported progress during the year would indicate that there is more good news on the way as a result of the big second half turnaround. The question remains as to how much of this turnaround is from the old TUTA business as opposed to the Medivet business. The segment reporting seems to indicate that the Medivet side is contributing a lot less than expected, especially Australia. Was it a good buy?
    It seems to me that TUTA must have really turned the corner! I will have a look at some of the overheads and offer some further comments later.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.